Finance Watch: Aiolos Launches With $245m Series A; OrbiMed’s New Funds Total $4.3bn

Big Rounds Dominate As Quarterly VC Totals Creep Higher

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.